Title: Liang J, et al. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. Bioorg Med Chem Lett. 2017 Jul 1;27(13):2974-2981.
148932-68-7 | 2-Amino-3-methoxybenzonitrile | AA00AC2D | MFCD09744022
175779-55-2 | TRIACONTYLMETHYLSILOXANE, DIMETHYLSILOXANE COPOLYMER | AA00ACC3
1961-72-4 | 3-Hydroxytetradecanoic acid | AA00ACQV | MFCD00059633
17514-66-8 | 5-Chloro-3-methylbenzo[b]thiophene 1,1-dioxide | AA00ACWB | MFCD00203484
158039-15-7 | Desfuroyl Ceftiofur Cysteine Disulfide | AA00AD3S | MFCD31562976
177200-76-9 | [1-[(Benzyloxy)Methyl]cyclopropyl]Methanol | AA00ADAC | MFCD26398597
147711-15-7 | Hesperetin 3,4-Diacetate | AA00ADG1
176039-39-7 | (Rs)-2-(boc-amino)-2-(fmoc-amino)-acetic acid | AA00ADP9 | MFCD00273452
148930-55-6 | 7-O-(Triethylsilyl) Paclitaxel | AA00ADWT | MFCD29920165
158754-46-2 | 8-Oxo-Benzylguanine | AA00AE3X | MFCD00872133